Onyx Biotec Ltd

Onyx Biotec Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Onyx Biotec Ltd

₹ 34.0 0.00%
12 Dec - close price
onyxbiotec.com NSE - SME: ONYX
About

Incorporated in 2005, Onyx Biotech Ltd manufactures and sells Sterile Water for Injections, Dry Powder Injections and Dry
Syrup for India and overseas, through a
B2B business model[1]

Key Points

Business Overview:[1]
OBL is associated with the healthcare segment and is a supplier of sterile pharmaceutical products to major corporations. Presently, OBL manufactures Sterile Water for Injections, and acts as a pharmaceutical contract manufacturer offering a comprehensive range of Dry Powder Injections and Dry Syrup for India and overseas. It provides end-to-end product development and manufacturing solutions and its services
also include preparation and filing of regulatory dossiers in the Indian and global markets.

Website NSE - SM
  • Market Cap ₹ 61.6 Cr.
  • Current Price ₹ 34.0
  • High / Low ₹ 97.4 / 30.5
  • Stock P/E 57.6
  • Book Value ₹ 30.2
  • Dividend Yield 0.00 %
  • ROCE 12.2 %
  • ROE 10.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Stock is trading at 1.13 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 12.2% over last 3 years.
  • Debtor days have increased from 90.2 to 119 days.
  • Working capital days have increased from 24.3 days to 87.5 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025
23.89 29.86 30.15 31.80 34.59
20.47 24.95 24.44 27.17 33.65
Operating Profit 3.42 4.91 5.71 4.63 0.94
OPM % 14.32% 16.44% 18.94% 14.56% 2.72%
0.04 0.09 0.99 0.18 0.24
Interest 0.83 1.27 1.36 0.62 0.55
Depreciation 0.73 1.14 1.53 1.51 1.56
Profit before tax 1.90 2.59 3.81 2.68 -0.93
Tax % 15.26% 21.24% 21.52% 26.12% -3.23%
1.60 2.03 2.99 1.97 -0.90
EPS in Rs 2.71 1.52 2.24 1.09 -0.50
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
44.86 39.49 53.75 61.95 66.39
39.09 34.99 45.36 51.57 60.82
Operating Profit 5.77 4.50 8.39 10.38 5.57
OPM % 12.86% 11.40% 15.61% 16.76% 8.39%
0.12 0.11 0.13 1.17 0.42
Interest 0.65 0.57 2.16 2.02 1.17
Depreciation 1.45 1.49 1.87 3.05 3.07
Profit before tax 3.79 2.55 4.49 6.48 1.75
Tax % 11.61% 27.45% 19.15% 23.46%
3.35 1.84 3.63 4.95 1.07
EPS in Rs 5.68 3.12 2.72 2.73 0.59
Dividend Payout % 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 11%
TTM: 11%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 8%
TTM: -79%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -37%
Return on Equity
10 Years: %
5 Years: %
3 Years: 12%
Last Year: 10%

Balance Sheet

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 5.90 5.90 13.32 18.13 18.13
Reserves 10.47 12.30 11.97 37.49 36.59
12.25 29.23 30.78 12.46 15.73
8.22 11.30 18.07 23.17 21.67
Total Liabilities 36.84 58.73 74.14 91.25 92.12
17.23 42.50 43.48 40.90 39.84
CWIP 4.02 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00
15.59 16.23 30.66 50.35 52.28
Total Assets 36.84 58.73 74.14 91.25 92.12

Cash Flows

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.49 1.96 1.52 1.42
-5.78 -22.68 -3.15 0.66
5.20 16.43 3.09 5.07
Net Cash Flow -0.09 -4.30 1.46 7.15

Ratios

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 68.51 46.95 104.37 119.19
Inventory Days 41.98 109.92 92.94 150.14
Days Payable 59.46 120.16 140.83 156.02
Cash Conversion Cycle 51.03 36.71 56.48 113.32
Working Capital Days 35.72 -52.22 37.62 87.49
ROCE % 8.23% 12.85% 12.16%

Shareholding Pattern

Numbers in percentages

3 Recently
Nov 2024Mar 2025Sep 2025
65.10% 65.10% 65.10%
8.72% 5.36% 1.95%
3.29% 2.39% 2.39%
22.89% 27.15% 30.56%
No. of Shareholders 1,181551640

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports